Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
复制标题

DOI:
10.1172/jci10498
复制
发表时间:
2000-12-01
影响因子:
15.9
通讯作者:
Zlokovic, BV
Zlokovic, BV
中科院分区:
医学1区
文献类型:
--
作者:
Shibata, M;Yamada, S;Zlokovic, BV

文献摘要

被引文献

相似文献

人们对淀粉样β肽(A β)从大脑中的消除知之甚少。在年轻小鼠脑内微量注射后,I-125-A β(1.40)迅速从脑中清除(t(1/2)小于或等于25分钟),主要是通过血脑屏障(BBB)的血管转运。BBB处A β(1.40)的外排转运系统在15.3 nM时达到半饱和,在70 nM至100 nM之间达到最大转运能力。受体相关蛋白、抗LDL受体相关蛋白-1(LRP-1)和α 2-巨球蛋白(α M-2)的抗体显著抑制β(1.40)清除率。与成年野生型小鼠相比,年轻和老年载脂蛋白E(apoE)敲除小鼠以及老年野生型小鼠的清除率显著降低。没有证据表明A β在脑间质液中代谢,并在其穿过BBB进入循环之前降解为较小的肽片段和氨基酸。LRP-1虽然在年轻小鼠的脑微血管中丰富,但在老年动物中下调,并且这种下调与阿尔茨海默病(AD)患者脑中的区域A β积累相关。我们的结论是,血脑屏障从大脑中删除A β主要是通过年龄依赖性,LRP-1介导的运输,受α M-2和/或apoE的影响,并可能在AD受损。
Elimination of amyloid-beta peptide (A beta) from the brain is poorly understood. After intracerebral microinjections in young mice,I-125-A beta (1.40) was rapidly removed from the brain (t(1/2) less than or equal to 25 minutes), mainly by vascular transport across the blood-brain barrier (BBB). The efflux transport system for A beta (1.40) at the BBB was half saturated at 15.3 nM, and the maximal transport capacity was reached between 70 nM and 100 nM. A beta (1.40) clearance was substantially inhibited by the receptor-associated protein, and by antibodies against LDL receptor-related protein-1 (LRP-1) and alpha (2)-macroglobulin (alpha M-2), As compared to adult wild-type mice, clearance was significantly reduced in young and old apolipoprotein E (apoE) knockout mice, and in old wild-type mice. There was no evidence that A beta was metabolized in brain interstitial fluid and degraded to smaller peptide fragments and amino acids before its transport across the BBB into the circulation. LRP-1, although abundant in brain microvessels in young mice, was downregulated in older animals, and this downregulation correlated with regional A beta accumulation in brains of Alzheimer's disease (AD) patients. We conclude that the BBB removes A beta from the brain largely via age-dependent, LRP-1-mediated transport that is influenced by alpha M-2 and/or apoE, and may be impaired in AD.